DIN 02504979 — BUPIVACAINE HYDROCHLORIDE INJECTION, USP 7.5 MG
BUPIVACAINE HYDROCHLORIDE INJECTION, USP is a solution of Bupivacaine marketed by STERIMAX INC. The full Bupivacaine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02504979
- Brand name
- BUPIVACAINE HYDROCHLORIDE INJECTION, USP
- Active ingredient
- Bupivacaine
- Strength
- 7.5 MG
- Dosage form
- SOLUTION
- Route
- EPIDURAL; RETROBULBAR
- Manufacturer
- STERIMAX INC
- Health Canada status
- DORMANT
- Drug class
- Amide-type local anesthetic
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Bupivacaine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02460645 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP | 7.5 MG | SOLUTION | STERIMAX INC | MARKETED |
| 02512424 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP | 7.5 MG | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED |
| 02536714 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP | 7.5 MG | SOLUTION | FORMATIVE PHARMA INC. | MARKETED |
| 02488930 | BUPIVACAINE HYDROCHLORIDE INJECTION, USP | 7.5 MG | SOLUTION | BAXTER CORPORATION | MARKETED |
| 02443686 | BUPIVACAINE INJECTION BP | 2.5 MG | SOLUTION | STERIMAX INC | MARKETED |
| 02443694 | BUPIVACAINE INJECTION BP | 5 MG | SOLUTION | STERIMAX INC | MARKETED |
| 02241917 | MARCAINE | 150 MG | SOLUTION | PFIZER CANADA ULC | MARKETED |
| 02305909 | MARCAINE | 250 MG | SOLUTION | PFIZER CANADA ULC | MARKETED |
| 02241914 | MARCAINE SPINAL | 15 MG | SOLUTION | PFIZER CANADA ULC | DORMANT |
| 01976141 | SENSORCAINE | 2.5 MG | SOLUTION | ASPEN PHARMACARE CANADA INC. | MARKETED |
| 01976168 | SENSORCAINE | 5 MG | SOLUTION | ASPEN PHARMACARE CANADA INC. | MARKETED |